Intellectual Property

  • April 26, 2024

    Off The Bench: Nassar Victims, Bush V. NCAA, New ACC Suit

    In this week's Off The Bench, the U.S. Department of Justice cuts a nine-figure deal for botching its sexual abuse investigation of disgraced USA Gymnastics physician Larry Nassar, college football legend Reggie Bush plows ahead with an NCAA defamation suit despite reclaiming his Heisman trophy, and Florida sues the ACC to detail its lucrative media rights contracts.

  • April 26, 2024

    JPMorgan Says Ex-Adviser Is Pilfering Clients For Wells Fargo

    J.P. Morgan has accused a former investment management adviser of trying to poach clients for her new job at a competing Wells Fargo unit, saying she's been making unsolicited phone calls and sending emails to convince clients to leave in breach of her employment contract.

  • April 26, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen budget airline Ryanair file a claim against NATS PLC after the air traffic controller's system collapsed, Mastercard and Visa Europe face group claims from Christian Dior and dozens of other beauty retailers, an intellectual property clash between the publisher of The Sun and ITV, and ISC Europe sue a former director for alleged money laundering. Here, Law360 looks at these and other new claims in the U.K.

  • April 25, 2024

    AI-Created Rant Tied To Principal Leads To Ex-Staffer's Arrest

    Baltimore County police on Thursday arrested a former high school athletic director who is accused of using artificial intelligence to generate a racist and antisemitic audio recording falsely attributed to the school's principal, allegedly in retaliation for an investigation into the potential mishandling of school funds.

  • April 25, 2024

    Astellas Can't Block Generic Myrbetriq Amid Patent Suit

    A Delaware federal judge has shot down Astellas Pharma's request to issue an injunction blocking rival pharmaceutical companies from selling generic copies of the overactive bladder medication Myrbetriq as they hash out a patent infringement suit, agreeing with a magistrate judge that Astellas isn't likely to win its case.

  • April 25, 2024

    CureVac, Acuitas Reach Deal In COVID Vax Patent Dispute

    CureVac SE told a Virginia federal judge Thursday that it has reached a settlement to resolve Acuitas Therapeutics Inc.'s lawsuit inventorship credit on patents related to lipid nanoparticle technology used to develop the blockbuster Pfizer and BioNTech COVID-19 vaccine.

  • April 25, 2024

    Meta Can't Get TTAB To Dismiss Software Biz's TM Challenge

    An administrative tribunal has dealt a setback to the tech giant formerly known as Facebook in its legal efforts to register a trademark covering its new moniker, allowing an Italian software company called myMeta to proceed with arguments that it was first.

  • April 25, 2024

    GSK Hits Pfizer And BioNTech With COVID Vaccine Patent Suit

    GlaxoSmithKline alleged in a suit filed Thursday in Delaware federal court that the COVID-19 vaccines made by Pfizer and BioNTech infringe five of its patents on mRNA technology, the latest in a series of lawsuits over the vaccines that have generated tens of billions of dollars in revenue.

  • April 25, 2024

    Judge Reopens Allstate Trade Secrets Case Against Ex-Agent

    A Colorado federal judge has partially reopened a case alleging that a former Allstate exclusive agent poached customers for another agency, directing the ex-agent to explain why he shouldn't be held in contempt in the lawsuit.

  • April 25, 2024

    7th Circ. OKs Pausing Nail Polish IP Suit For Ownership Fight

    A company registered in New Jersey that sells nail polish has failed to persuade a federal appeals court to let it move ahead with its trade secrets case in a Chicago federal court against its former business partners in China until first resolving an ownership dispute "lurking just beneath the surface."

  • April 25, 2024

    Dominican Republic, Uzbekistan No Longer On IP Watch List

    The Office of the U.S. Trade Representative announced Thursday it has removed the Dominican Republic and Uzbekistan from its watch list of countries with poor track records on intellectual property protection, keeping close trade partners Mexico and Canada on the roster.

  • April 25, 2024

    Patent Holder Settles Transfer Fraud Case Tied To $17M Win

    The holder of a patent on a device that prevents New York City subways from flooding on Thursday settled a case adjacent to a $17.8 million infringement feud by agreeing to accept $850,000 from an individual and two companies accused of helping siphon money away from the infringers.

  • April 25, 2024

    TikTok Wins Partial Toss Of Chinese Co.'s IP Suit

    A California federal judge has granted TikTok's motion to dismiss many intellectual property claims against it by Chinese software company Beijing Meishe Network Technology but gave the plaintiff a chance to amend some of the claims.

  • April 25, 2024

    Atty Slams Mogul's Fight For Bank Records As Waste Of Time

    An attorney struck back against an airline mogul's attempt to acquire his bank records as part of a hacking lawsuit, telling a federal court that a subpoena was invalid because it was sent under an improper bank name.

  • April 25, 2024

    Ex-Burns & Levinson Life Sciences Chair Joins Polsinelli

    Polsinelli PC announced that the former life sciences co-chair at New England firm Burns & Levinson LLP has joined its Boston office as a shareholder. 

  • April 25, 2024

    Class Counsel Seeks $31M From $93M Lipitor Settlement

    Attorneys representing a class of buyers in antitrust litigation against Pfizer over the cholesterol medication Lipitor have asked a New Jersey federal judge to approve their request for $31 million in fees after the two sides agreed to a $93 million settlement in February.

  • April 25, 2024

    Digital Health Co.'s Former GC Joins Perkins Coie In NY

    Perkins Coie LLP is bolstering its intellectual property practice, announcing Thursday that it has brought on the former general counsel and chief compliance officer of digital healthcare company Cleerly.

  • April 25, 2024

    Ohio Deer Repellent Co. Hit With Trade Secrets Suit In NJ

    A New Jersey deer repellent company claims that an Ohio company, which was formerly a licensee, is stealing trade secrets by continuing to use its proprietary techniques and procedures after the licensing agreement lapsed.

  • April 25, 2024

    Sheppard Mullin Hires Perkins Coie IP Partner In DC

    Sheppard Mullin Richter & Hampton LLP has hired an intellectual property attorney from Perkins Coie LLP, who is the third patent-focused litigator to leave that firm this week.

  • April 24, 2024

    Lyft Denied $1M Fees In Patent Suit Because Of Previous Deal

    A California federal judge on Tuesday denied Lyft Inc.'s request for $1 million in attorney fees in its patent dispute against Quartz Auto Technologies LLC, saying the parties' agreement to dismiss certain claims clearly stated that each party would "bear its own costs and attorneys' fees."

  • April 24, 2024

    'Black-ish' Actress Beats Suit Alleging She Stole Spinoff Idea

    A California appeals court permanently ended on Monday a suit alleging actress Tracee Ellis Ross and producers of "Mixed-ish" stole a writer's ideas for a sitcom based on a mixed-race character growing up in the suburbs, finding there are no substantial similarities between the two shows.

  • April 24, 2024

    NC Biz Court Trims School Food Servicer's Noncompete Suit

    The North Carolina Business Court on Wednesday pared a cafeteria food provider's lawsuit alleging a former sales director absconded with confidential information to a rival business, reasoning the Tar Heel State's laws aren't applicable over alleged out-of-state conduct.

  • April 24, 2024

    Feds Want Disbarred Atty's FOIA Suit Over USPTO Docs Axed

    The federal government urged a North Carolina federal court Wednesday to toss a disbarred attorney's sprawling Freedom of Information Act lawsuit over U.S. Patent and Trademark Office documents, arguing the case is one of a dozen duplicative, meritless suits the plaintiff has filed.

  • April 24, 2024

    3 Takeaways On How AI Is Forcing Publicity Rights To Evolve

    As digital replicas of someone's voice, image or likeness become easier to create with the help of artificial intelligence, this new era of deepfakes is shining a spotlight on the nation's patchwork of right-of-publicity laws and raising questions over when Congress may act to pass a national framework.  

  • April 24, 2024

    Map Co. Objects To Recommendation Of Tossing IP Case

    A mapping company has taken issue with a recommendation by a federal magistrate judge in New York that its copyright infringement lawsuit against environmental risk assessment data company ERIS Information should be tossed.

Expert Analysis

  • Medtronic's Cautionary Tale Of Fed. Circ. Word Limits

    Author Photo

    The Federal Circuit's ruling in Medtronic v. Teleflex that Medtronic waived an argument that it had sought to incorporate by reference illustrates the pitfalls facing parties in complex patent cases involving numerous issues that cannot all be addressed within the strict word limits for appellate briefs, say Sean Murray and Jeremiah Helm at Knobbe Martens.

  • What One Litigator Learned Serving On A Jury

    Author Photo

    Kilpatrick attorney April Isaacson shares insights for trial lawyers from her recent experience serving on a jury for the first time, including lessons about the impact of frequent sidebars, considerations for using demonstratives, the importance of clear jury instructions, and the unconscious habits that can drive jurors mad.

  • Lessons In Navigating Collateral Estoppel Of Similar Patents

    Author Photo

    The Patent Trial and Appeal Board's recent holding in Google v. Parus that rehearing was appropriate under collateral estoppel illustrates best arguments in inter partes review for any issue that could arise in a later proceeding, including dependent claim limitations, say attorneys at Akin.

  • Fed. Circ. Ruling Seemingly Offers PTAB Deadline Immunity

    Author Photo

    The Federal Circuit's recent Purdue Pharma v. Collegium Pharmaceutical Inc. decision that the Patent Trial and Appeal Board had authority to issue a final written decision in a post grant review after the prescribed statutory deadline underscores how courts should consider the overall objective of the statutory scheme when balancing the classic conflict between bright-line rules and flexible standards, says Matthew Dowd at Dowd Sheffel.

  • 4 Legal Ethics Considerations For The New Year

    Author Photo

    As attorneys and clients reset for a new year, now is a good time to take a step back and review some core ethical issues that attorneys should keep front of mind in 2024, including approaching generative artificial intelligence with caution and care, and avoiding pitfalls in outside counsel guidelines, say attorneys at HWG.

  • What Brands Need To Know About Consumer Reviews In 2024

    Author Photo

    Testimonials, endorsements and consumer reviews have been on the Federal Trade Commission's radar for years — and since this evolving area will continue to be an enforcement priority in 2024, now is the time to ensure your house is in order, say attorneys at Crowell & Moring.

  • Opinion

    Waiving COVID-19 IP Protections Would Harm US Industry

    Author Photo

    President Joe Biden should turn down a World Trade Organization proposal to waive crucial intellectual property protections behind COVID-19 tests and diagnostics — protections that allow U.S. companies to sustain millions of jobs and develop life-saving treatments that benefit patients in every country, says former U.S. Circuit Judge Paul Michel, now at the Council for Innovation Promotion.

  • Fed. Circ. Patent Decisions In 2023: An Empirical Review

    Author Photo

    The Federal Circuit decided 306 patent cases last year, which is still well down from the pre-pandemic norm of around 440, and on the whole the court's decisions were markedly less patentee-friendly in 2023 than in 2022, says Dan Bagatell at Perkins Coie.

  • What The Law Firm Of The Future Will Look Like

    Author Photo

    As the legal landscape shifts, it’s become increasingly clear that the BigLaw business model must adapt in four key ways to remain viable, from fostering workplace flexibility to embracing technology, say Kevin Henderson and Eric Pacifici at SMB Law Group.

  • 4 PR Pointers When Your Case Is In The News

    Author Photo

    Media coverage of new lawsuits exploded last year, demonstrating why defense attorneys should devise a public relations plan that complements their legal strategy, incorporating several objectives to balance ethical obligations and advocacy, say Nathan Burchfiel at Pinkston and Ryan June at Castañeda + Heidelman.

  • Trouble Indemnity: IP Lawsuits In The Generative AI Boom

    Author Photo

    Attorneys at Ropes & Gray explore the contours of the intellectual property indemnification protections offered by providers of generative AI models — including their scope, coverage, conditions, exclusions and caps — to assess where businesses may still face liability exposure.

  • 6 AI Cases And What They Mean For Copyright Law

    Author Photo

    Artificial intelligence cases filed last year, some decided and others pending, demonstrate how the appellate courts that set binding precedent look at the intersection between copyright and AI, so legal frameworks must adapt and provide clarity in order to foster innovation, protect creators, and ensure fair and equitable outcomes, say attorneys at Crowell & Moring.

  • Why Fed. Circ. Affirmed Attorney Fee Award In PersonalWeb

    Author Photo

    A recent Federal Circuit decision to leave a $5.2 million fee award in place in the PersonalWeb patent case underscores district courts' discretion to sanction unreasonable arguments and litigation tactics under the U.S. Code's attorney fee provision, say attorneys at Shearman. 

  • How AI Is Changing The Game Of Professional Sports

    Author Photo

    As more professional sports teams and organizations employ the use of artificial intelligence, counsel should keep a critical eye on several legal issues, including both state and federal regulatory developments, data privacy concerns, and how AI tools could potentially affect applicable intellectual property rights, say attorneys at Squire Patton.

  • Trending At The PTAB: 6 Areas To Watch In 2024

    Author Photo

    Expect further changes in a half-dozen areas in 2024 following a busy 2023 at the Patent Trial and Appeal Board, including more adjustments to the director review process and the first case to hit the Appeals Review Panel, say attorneys at Finnegan.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!